Used in pharmaceutical research as a protected intermediate in the synthesis of paclitaxel derivatives. The triethylsilyl group protects the 7-hydroxyl function during selective modifications at other sites on the paclitaxel core, enabling the development of novel analogs with potential anticancer activity. This derivative is particularly valuable in structure-activity relationship studies and in improving the solubility or stability of paclitaxel during synthetic processes.